Liver resectability of advanced liver-limited colorectal liver metastases following mFOLFOX6 with bevacizumab (KSCC0802 Study)

The Kyushu Study group of Clinical Cancer (KSCC) conducted phase II trials (KSCC0802-UMIN000001308) concerning liver resectability after first-line treatment of advanced liver-limited colorectal metastases (CRLM) by a prospective, multi-center study. Patients received 6 cycles of mFOLFOX6 with bevac...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Anticancer research 2014-11, Vol.34 (11), p.6655-6662
Hauptverfasser:	Beppu, Toru, Emi, Yasunori, Tokunaga, Shoji, Oki, Eiji, Shirabe, Ken, Ueno, Shinichi, Kuramoto, Masafumi, Kabashima, Akira, Takahashi, Ikuo, Samura, Hironori, Eguchi, Susumu, Akagi, Yoshito, Natsugoe, Shoji, Ogata, Yutaka, Kakeji, Yoshihiro, Baba, Hideo, Maehara, Yoshihiko
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Antibodies, Monoclonal, Humanized - administration & dosage Antineoplastic Combined Chemotherapy Protocols - therapeutic use Bevacizumab Clinical Trials, Phase II as Topic Colorectal Neoplasms - drug therapy Colorectal Neoplasms - mortality Colorectal Neoplasms - pathology Colorectal Neoplasms - surgery Combined Modality Therapy Female Fluorouracil - administration & dosage Follow-Up Studies Hepatectomy Humans Leucovorin - administration & dosage Liver Neoplasms - drug therapy Liver Neoplasms - mortality Liver Neoplasms - secondary Liver Neoplasms - surgery Male Middle Aged Neoplasm Staging Organoplatinum Compounds - administration & dosage Prognosis Prospective Studies Survival Rate
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!